ReviewOncoTargets and therapy2018

The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis.

Min Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.